Benzinga's Top Downgrades By: Benzinga via Benzinga March 21, 2016 at 09:30 AM EDT Analysts at Barclays downgrades Valeant Pharmaceuticals Intl Inc (NYSE: VRX) from Overweight to Equal-weight. The target price for ... Read More >> Related Stocks: Copart Inc Intel Corp NetApp Nordstrom United Dominion Realty Trust United States Steel Corp Valeant Pharmaceuticals International, Inc. Xylem